RSS-Feed abonnieren

DOI: 10.1055/a-2668-3461
Success and Challenges Querying OMOP-transformed EHR Data from Different Healthcare Organizations
Funding None declared.
- Abstract
- Introduction
- Materials and Methods
- Results
- Discussion
- Clinical Relevance Statement
- Multiple Choice Questions
- References
Abstract
Background
Adoption of a common data model (CDM), such as the Observational Medical Outcomes Partnership (OMOP) CDM, is a critical component of health information exchange, but the extent to which CDMs facilitate patient-level interoperability is unclear. We sought to determine the feasibility of using a CDM for health information exchange between two healthcare organizations.
Materials and Methods
We executed a single Structured Query Language (SQL) query on OMOP-transformed data from the University of California, San Francisco (UCSF) and the San Francisco VA Healthcare System for five patients.
Results
The SQL query was successfully executed, and complementary healthcare information was obtained for five of five patients, but interoperability was limited by (1) lack of uniform patient identifiers, (2) use of different coding vocabularies, and (3) variations in mapping of source data to the CDM.
Conclusion
Although transformation of EHR data to a CDM can facilitate health information exchange, our study suggests that patient-level interoperability of a CDM may require further alignment of both semantics and syntax.
Introduction
United States (US) healthcare encompasses a diverse array of provider and payer organizations that rely on a variety of electronic health record (EHR) systems which collect and store data in different manners. The wide range of data capture, coding, organization, and storage methods makes information sharing difficult and leads to care fragmentation when patients inevitably obtain services in different medical settings. Recognizing these challenges, the US 21st Century Cures Act included provisions to promote EHR data interoperability, prevent information blocking, and ensure flow of crucial healthcare data to end-user clinicians.[1]
To implement this legislation, the Office of the National Coordinator (ONC) created “The Trusted Exchange Framework and Common Agreement” that describes a set of non-binding, foundational principles for trust policies and practices to facilitate exchange among health information networks (HINs).[2] The ONC also created the United States Core Data for Interoperability, a set of individual data elements that have been deemed critically important to promote interoperability.[3] Capture of these data elements is one of the criteria required for certification of application programming interfaces for patient and population services.[3]
However, capture of data elements is only the first step required for health information exchange. Structured data must also be accessible, retrievable, and readable by providers at other healthcare organizations. Network services, such as Carequality (used in Epic's Care Everywhere) and CommonWell Health Alliance, facilitate health information exchange, but both structured and unstructured data elements are presented in cumbersome text summaries that preclude easy retrieval by providers at other healthcare organizations. To find a laboratory value, for example, a clinician must search through a lengthy healthcare summary (including patient demographics, medications, procedures, immunizations, and vital signs) rather than viewing the result in a structured, labeled, and searchable data field as it would be seen in the source EHR.
The Fast Healthcare Interoperability Resources (FHIR) standard enables secure exchange of health information through an application programming interface. It can be used in a wide range of settings and with different health information systems, but it does not generate humanly readable output. Of note, FHIR focuses on rapid, flexible transfer of healthcare data and does not require harmonization of source data. This difference sets FHIR apart from common data models (CDMs) such as the Observational Medical Outcomes Partnership (OMOP) CDM, differentiating it as a separate tool for interoperability. Ongoing efforts, like OMOP on FHIR, have used both tools to share harmonized data between organizations.[4]
Although the USCDI sets a foundation for sharing of EHR information to support patient care, it does not stipulate any specific CDM, enforce universal standards or taxonomies for the collection of variables, specify acceptable values, or establish internal relationships between data elements. CDMs provide valuable frameworks, structure, methods, and tools to convert source data into a common language (even allowing conversion of records in written languages other than English from healthcare systems beyond the US such as France[5]) that can be spoken and understood by different healthcare systems. Therefore, use of a CDM, such as the Biomedical Research Integrated Domain Group (BRIDG)[6] or harmonize,[7] could theoretically improve interoperability and health information exchange, depending on source data structure.
OMOP was a public–private partnership that was initially organized in response to the FDA amendments Act of 2007 due to the need for greater pharmacovigilance (The Future of Drug Safety).[8] Because pharmacovigilance often requires observational data generated outside of large randomized controlled trials, OMOP developed a person-centric relational data model called the OMOP-CDM.[8] [9] [10] The OMOP-CDM featured multiple domains including demographics, observation periods, drug exposures, condition occurrences, procedures, visits, and clinical observations.[9] [10] Further expansion and curation of the OMOP-CDM and the creation of complementary analytical tools has been overseen by the not-for-profit Observational Health Data Sciences and Informatics (OHDSI) collaborative.[11]
Multiple publications document the conversion of a wide variety of source data to the OMOP-CDM and successful analysis of these data using interoperable common methods that are source agnostic.[9] [12] [13] [14] [15] These studies demonstrate a key feature of the OMOP-CDM—healthcare data interoperability for research—but have not examined its potential use for clinical and operational healthcare coordination. Like most healthcare CDMs, OMOP stores data in star schema relational database management systems accessed using Structured Query Language (SQL), but whether conversion of source data to the OMOP-CDM enables a single SQL query to obtain complementary clinical data across different healthcare systems is unknown. Therefore, we sought to query OMOP-transformed data from two healthcare systems using a single SQL script designed to obtain healthcare information for patients seen at both the institutions [Fig. 1].
Materials and Methods
As part of the patient-centered Scalable National Network for Effectiveness Research (pSCANNER) project,[16] health data from the San Francisco VA (SFVA) and University of California, San Francisco (UCSF) were extracted, transformed, and loaded (ETL) into parallel databases using the OMOP-CDM. Data from the SFVA was extracted from the Corporate Data Warehouse, a relational database that contains a nightly ETL of clinical data from the Veterans Health Information Systems and Technology Architecture (VistA).[17] Data from UCSF's Epic Clarity Data Model were extracted and transformed to the OMOP-CDM.[16]
After obtaining study approval from the UCSF Institutional Review Board and the SFVA Research & Development Committee, we identified nine deceased patients who were known to have received care at both the institutions. Each patient was identified using Social Security Number (SSN), and we used SSN/OMOP PERSON_ID crosswalks to identify OMOP PERSON_ID at both VA and UCSF. All nine patients had records within VHA, but only five out of nine patients were identified within UCSF OMOP. After identification of patients' OMOP PERSON_IDs, both the VHA and UCSF OMOP instances were queried using the SQL code shown in [Fig. 2]. The SQL query was designed to output counts of laboratory tests, clinical visits, and procedures by joining five (Concept, Person, Procedure_occurrence, Provider, and Visit_occurrence) OMOP tables. The OMOP Concept IDs used to obtain count data are shown in [Table 1]. Initially only VHA specific non-standard CONCEPT_IDs (based on the National Uniform Claim Committee [NUCC] vocabulary) were used for physician specialty, but after finding no results at UCSF, the query was expanded to include standard CONCEPT_IDs (based on Medicare Specialty) which identified visit occurrences at UCSF. Minor changes in the code were required between the VHA and UCSF OMOP instance queries due to different schema and project provisioning naming conventions. Output from the queries was collected and organized in tabular format.




Results
[Table 2] presents the output of count values from the SQL query. Each row shows the count of a specific test, visit occurrence, or procedure occurrence within each facility. Columns represent the source of these data counts (SFVA, UCSF, or the combined sum of counts across both healthcare systems). The most commonly occurring measurement was creatinine, with a total of 187 separate measurements (159 VHA + 28 UCSF) across 5 patients. The most commonly occurring procedure was EKG interpretation, with a total report of 82 EKG interpretations (61 VHA + 21 UCSF). As above, UCSF and SFVA used separate concepts to describe visit occurrence (UCSF uses Medicare Specialty whereas VHA uses NUCC). At UCSF, the most common visit occurrence was with Ophthalmology (22 visits total), whereas at the SFVA the most common occurrence was with General Internal Medicine (231 visits total).
OMOP CONCEPT |
Vocab |
Patient 1 |
Patient 2 |
Patient 3 |
Patient 4 |
Patient 5 |
Sum |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UC |
VA |
C |
UC |
VA |
C |
UC |
VA |
C |
UC |
VA |
C |
UC |
VA |
C |
UC |
VA |
C |
||
Measurement Table |
|||||||||||||||||||
Alkaline Phosphatase |
LOINC |
14 |
0 |
14 |
3 |
5 |
8 |
29 |
29 |
13 |
1 |
14 |
10 |
3 |
13 |
69 |
9 |
78 |
|
Bilirubin |
LOINC |
14 |
14 |
3 |
5 |
8 |
29 |
29 |
13 |
1 |
14 |
10 |
2 |
12 |
69 |
8 |
77 |
||
Cholesterol |
LOINC |
1 |
1 |
4 |
4 |
18 |
18 |
5 |
1 |
6 |
5 |
4 |
9 |
33 |
5 |
38 |
|||
Creatinine |
LOINC |
55 |
55 |
6 |
6 |
12 |
63 |
63 |
29 |
2 |
31 |
6 |
20 |
26 |
159 |
28 |
187 |
||
Hemoglobin |
LOINC |
51 |
51 |
5 |
3 |
8 |
42 |
42 |
26 |
2 |
28 |
8 |
19 |
27 |
132 |
24 |
156 |
||
Hemoglobin A1c in Serum or Plasma |
LOINC |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Hemoglobin A1c measurement device panel |
LOINC |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Hemoglobin A1c/Hemoglobin total in Blood |
LOINC |
3 |
3 |
0 |
0 |
3 |
3 |
1 |
1 |
7 |
0 |
7 |
|||||||
HIV 1 + 2 AB [Presence] In Serum |
LOINC |
1 |
1 |
0 |
0 |
2 |
2 |
1 |
1 |
4 |
0 |
4 |
|||||||
HIV 1 Ab in Serum or Plasma by Immunoassay |
LOINC |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Procedure Table |
|||||||||||||||||||
Comprehensive Eye Examination |
SNOMED |
1 |
1 |
1 |
1 |
21 |
21 |
2 |
2 |
1 |
1 |
26 |
0 |
26 |
|||||
Echocardiography |
SNOMED |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
3 |
3 |
6 |
0 |
6 |
||||||
Echocardiography Transthoracic, Real-time |
CPT4 |
1 |
1 |
2 |
2 |
0 |
15 |
2 |
17 |
7 |
12 |
19 |
23 |
16 |
39 |
||||
Electrocardiogram, interpretation and report only |
CPT4 |
24 |
24 |
5 |
5 |
16 |
16 |
15 |
1 |
16 |
6 |
15 |
21 |
61 |
21 |
82 |
|||
Electrocardiogram, tracing only |
CPT4 |
24 |
24 |
3 |
3 |
16 |
16 |
0 |
1 |
16 |
17 |
41 |
19 |
60 |
|||||
Electrocardiogram with interpretation and report |
CPT4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Fitting of Hearing Aid |
CPT4 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
1 |
|||||||||
Hearing Aid Check; Binaural |
CPT4 |
0 |
0 |
1 |
1 |
11 |
11 |
2 |
2 |
14 |
0 |
14 |
|||||||
Hearing Aid Check; Monaural |
CPT4 |
0 |
0 |
0 |
4 |
4 |
0 |
4 |
0 |
4 |
|||||||||
Hearing Aid Examination and Selection; Binaural |
CPT4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Low Dose Computed Tomography of Thorax |
SNOMED |
0 |
0 |
0 |
2 |
2 |
0 |
2 |
0 |
2 |
|||||||||
Ophthalmic Examination and Evaluation |
SNOMED |
0 |
0 |
10 |
10 |
24 |
24 |
0 |
34 |
0 |
34 |
||||||||
Physical Therapy Evaluation (Deprecated) |
CPT4 |
2 |
2 |
0 |
3 |
3 |
1 |
1 |
1 |
1 |
2 |
7 |
1 |
8 |
|||||
Physical Therapy Evaluation; High Complexity |
CPT4 |
0 |
0 |
1 |
1 |
1 |
1 |
0 |
2 |
0 |
2 |
||||||||
Physical Therapy Evaluation; Low Complexity |
CPT4 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
||||||||
Physical Therapy Evaluation; Moderate Complexity |
CPT4 |
0 |
0 |
0 |
1 |
1 |
0 |
1 |
0 |
1 |
|||||||||
Provider Visit Occurrence Table |
|||||||||||||||||||
General Internal Medicine |
NUCC |
33 |
33 |
17 |
17 |
95 |
95 |
51 |
51 |
35 |
35 |
231 |
0 |
231 |
|||||
Cardiology |
NUCC |
27 |
27 |
0 |
18 |
18 |
14 |
14 |
11 |
11 |
70 |
0 |
70 |
||||||
Cardiology, Electrophysiology |
NUCC |
0 |
0 |
1 |
1 |
2 |
2 |
0 |
3 |
0 |
3 |
||||||||
Cardiology, Interventional |
NUCC |
2 |
2 |
0 |
8 |
8 |
9 |
9 |
1 |
1 |
20 |
0 |
20 |
||||||
Dermatology |
NUCC |
0 |
0 |
6 |
6 |
0 |
0 |
6 |
0 |
6 |
|||||||||
Endocrinology |
NUCC |
1 |
1 |
0 |
1 |
1 |
0 |
0 |
2 |
0 |
2 |
||||||||
Geriatrics |
NUCC |
0 |
0 |
2 |
2 |
2 |
2 |
1 |
1 |
5 |
0 |
5 |
|||||||
Hematology / Oncology |
NUCC |
0 |
0 |
18 |
18 |
0 |
0 |
18 |
0 |
18 |
|||||||||
Nephrology |
NUCC |
5 |
5 |
0 |
0 |
0 |
0 |
5 |
0 |
5 |
|||||||||
Medical Oncology |
NUCC |
0 |
0 |
2 |
2 |
6 |
6 |
0 |
8 |
0 |
8 |
||||||||
Palliative Care |
NUCC |
0 |
0 |
4 |
4 |
0 |
0 |
4 |
0 |
4 |
|||||||||
Infectious Disease |
NUCC |
0 |
0 |
0 |
9 |
9 |
0 |
9 |
0 |
9 |
|||||||||
Pulmonology |
NUCC |
1 |
1 |
0 |
0 |
0 |
8 |
8 |
9 |
0 |
9 |
||||||||
Rheumatology |
NUCC |
2 |
2 |
0 |
3 |
3 |
0 |
0 |
5 |
0 |
5 |
||||||||
Ophthalmology |
NUCC |
0 |
0 |
32 |
32 |
26 |
26 |
0 |
58 |
0 |
58 |
||||||||
Radiology, Nuclear Medicine |
NUCC |
0 |
0 |
1 |
1 |
3 |
3 |
1 |
1 |
5 |
0 |
5 |
|||||||
Radiology, Radiation Oncology |
NUCC |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Surgery, Surgical Oncology |
NUCC |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
General Internal Medicine |
Medicare Specialty |
0 |
0 |
0 |
0 |
2 |
2 |
0 |
2 |
2 |
|||||||||
Cardiology |
Medicare Specialty |
0 |
0 |
0 |
0 |
16 |
16 |
0 |
16 |
16 |
|||||||||
Cardiology, Electrophysiology |
Medicare Specialty |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Cardiology, Interventional |
Medicare Specialty |
0 |
0 |
0 |
0 |
7 |
7 |
0 |
7 |
7 |
|||||||||
Dermatology |
Medicare Specialty |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Endocrinology |
Medicare Specialty |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Geriatrics |
Medicare Specialty |
0 |
0 |
0 |
0 |
4 |
4 |
0 |
4 |
4 |
|||||||||
Hematology / Oncology |
Medicare Specialty |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Nephrology |
Medicare Specialty |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Medical Oncology |
Medicare Specialty |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Palliative Care |
Medicare Specialty |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Infectious Disease |
Medicare Specialty |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Pulmonology |
Medicare Specialty |
0 |
0 |
0 |
0 |
9 |
9 |
0 |
9 |
9 |
|||||||||
Rheumatology |
Medicare Specialty |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Ophthalmology |
Medicare Specialty |
0 |
0 |
0 |
16 |
16 |
6 |
6 |
0 |
22 |
22 |
||||||||
Radiology, Nuclear Medicine |
Medicare Specialty |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||||||
Radiology, Radiation Oncology |
Medicare Specialty |
0 |
0 |
6 |
6 |
0 |
0 |
0 |
6 |
6 |
UC = University of California, San Francisco; VA = San Francisco VA; C = Combined; NUCC = National Uniform Claim Committee.
Discussion
We sought to evaluate the feasibility of executing a single SQL query on parallel OMOP instances from two separate healthcare systems. We found that the queries executed successfully and retrieved complementary information for five patients, underscoring the value of the CDM. The fact that very similar code was successfully executed and provided complementary patient data demonstrates the value of CDMs to harmonize health data from disparate systems. However, several challenges were encountered: lack of a uniform patient identifier; use of different standardized vocabularies (e.g., CPT versus ICD-10 versus SNOMED-CT procedure codes, Medicare versus NUCC provider classification, RxNORM versus National Drug Codes, HCPCS versus LOINC codes for durable medical equipment); and varied ETL mapping (e.g., to measurement versus observation tables) for the same data elements, which may not have followed CDM-specified conventions for mapping standardization across vocabularies.
The largest challenge was simply linking patients across the two healthcare systems. Because the two systems generated separate OMOP patient IDs, we had to rely on source data to link patients. Even within the source data, there was no uniform identifier other than SSN. Therefore, we had to (1) use SSNs to link patients in the source records and (2) create a crosswalk to link those SSNs with different OMOP patient identifiers in the two healthcare systems. The use of disparate patient identifiers across healthcare systems is emblematic of a significant weakness within the US healthcare system—lack of a Uniform Personal Identifier (UPI). In the past, development of a UPI has been banned due to privacy concerns, but paradoxically, using SSNs as the only unique health identifier risks even greater privacy threats because of its use in so many other domains. However, the recent growth and expansion of Qualified Health Information Networks may render the FHIR patient.identifier a de facto UPI in the US and beyond.[2] [18] In 2007 the RAND Corporation estimated that the US would save nearly $77 billion per year with implementation of a UPI for 90% of patients.[19]
Multiple Northern European countries have developed identification numbers that act as UPIs. Denmark uses the Danish Civil Registration System (DCRS) to generate the Central Person Register (CPR), a 10-digit number that includes a 6-digit date of birth plus a 4-digit serial number with a check digit (females even, males odd) for sex at birth.[20] Another well-implemented UPI is the Swedish Personal Identity Number (PIN).[21] Both the Swedish PIN and Danish CPR numbers are less error prone than the SSN because they incorporate a check digit.[20] [21] However, their use is not limited to healthcare. Like the SSN, they are used in multiple national registries that include both healthcare and non-healthcare domains.
Another issue was use of different vocabularies and taxonomies in the source data. In their 2022 recommendations for achieving interoperable and shareable medical data in the US, Szarfman et al said the lack of comprehensive, centrally coordinated medical data collection and transmission standards results in loss of information, inefficient operations, and huge costs.[22] Our findings underscore these conclusions. During the original design of our SQL query, multiple CONCEPT_IDs for measurements (laboratories), visit occurrences, and procedures were specified based on queries of the VA OMOP instance using text matching wildcard statements. These statements generated the list of CONCEPT_IDs used to query the UCSF OMOP instance ([Table 1]). However, no visit occurrences were identified at the UCSF using these CONCEPT_IDs, and visits were found only after adding physician specialty concepts from a different vocabulary. In addition, counts of measurements, procedures, and visits at the UCSF were much lower with these specific CONCEPT_IDs than when wildcard statements were used. This suggests that the two healthcare systems used different vocabularies and mapping.
The third challenge was variance in the ETL applied to transform source data into the OMOP CDM. Although redundancy is a strength of the OMOP CDM, it presents challenges when the same healthcare event can be represented in multiple ways. For example, one data transformation may map a laboratory procedure to CONCEPT_IDs for LOINC codes whereas another may map the same procedure to CONCEPT_IDs for CPT codes. A similar issue was encountered in a previous study that attempted to obtain medication exposure data[22] from OMOP-transformed data. In a VHA healthcare system, medication exposure was derived from dispensing events, whereas exposure was derived from physician orders in Partner's Health. Again, these challenges underscore the conclusions of Szarfman et al, who stated, “mapping and remapping from the irregular codes of each health information system to the standardized versions needed for exchanging data is an error-prone, inefficient, and costly process.”[21] Greater attention to standardized mapping could potentially address some of these issues.[23] For example, mapping a CPT code to a CONCEPT_ID could automatically populate the LOINC code CONCEPT_ID for that same procedure, and mapping a NUCC code to a non-standard CONCEPT-ID could automatically populate the corresponding (Medicare) standard CONCEPT_ID for that provider type.
Our study was limited by testing between only two institutions, for only five patients, and querying a limited number of OMOP tables (five total tables queried). In addition, we were unable to perform chart review validation of the queries as the authors do not have EHR access at both the healthcare systems. The small sample size, lack of chart review validation, and number of queried tables may have limited demonstration of interoperability, though the presence of instances of laboratory testing suggest against this being the case. Despite these limitations, results of this study may be generalizable given the standardized nature of the OMOP CDM and prior studies that note OMOP to operate similarly with other CDMs during comparison.[24] [25]
We are not aware of any previous publication describing experience executing a single SQL query on CDM-transformed data from two healthcare systems. This article documents the unexpected challenges we encountered when attempting to execute what should have been an easy process between two healthcare organizations with OMOP-transformed EHR data. In conclusion, we verified that use of a single SQL script to query OMOP-transformed data yielded complementary information from two separate institutions with alteration of only the OMOP patient ID and table prefixes. However, interoperability was limited by lack of a UPI, use of separate vocabularies in the source systems, and different ETL mapping. These findings suggest that a UHI, and greater attention to mapping standardization across CDM vocabularies, could further enhance interoperability.
Clinical Relevance Statement
This paper provides an example of how a CDM might be used to obtain complementary information about patients who receive healthcare from more than one source and identifies challenges for healthcare organizations and policy makers to consider when implementing a healthcare CDM.
Multiple Choice Questions
-
What is the purpose of the Observational Medical Outcomes Partnership (OMOP) common data model (CDM)?
-
To facilitate interoperability between different healthcare organization
-
To exchange information about clinical events from two different databases in a single language
-
To translate medical records from French to English
-
All of the above
-
Both a and b
The correct answer is option e.
-
-
Which of the following are considered standardized vocabularies?
-
Systematized Medical Nomenclature of Medicine–Clinical Terminology (SNOMED-CT)
-
International Classification of Diseases 10 (ICD-10)
-
Logical Observation Identifiers Names and Codes (LOINC)
-
All of the above
The correct answer is option e.
-
Conflict of Interest
None declared.
Protection of Human and Animal Subjects
Use of EHR data from five separate deceased patients who received care at both the UCSF and SFVA was approved by the UCSF Institutional Review Board (IRB) and the SFVA Research & Development Committee.
-
References
- 1 Congress. 21st Century Cures Act. Secondary 21st Century Cures Act 2016 . Accessed August 16, 2024 at: https://www.congress.gov/114/plaws/publ255/PLAW-114publ255.pdf
- 2 Health IT.gov. Trusted Exchange Framework and Common Agreement (TEFCA). Accessed August 16, 2024 at: https://www.healthit.gov/topic/interoperability/policy/trusted-exchange-framework-and-common-agreement-tefca
- 3 Health IT.gov. Interoperability Standards Advisory (ISA). United States Core Data for Interoperability (USCDI). Accessed August 16, 2024 at: https://www.healthit.gov/isp/
- 4 Choi M, Starr R, Riley M, Duke J. OMOP on FHIR for Data Analytic Application Platform. Accessed December 16, 2024 at: https://www.ohdsi.org/web/wiki/lib/exe/fetch.php?media=resources:omoponfhir_for_data_analytics.pdf/
- 5 Lamer A, Depas N, Doutreligne M. et al. Transforming French electronic health records into the Observational Medical Outcome Partnership's common data model: a feasibility study. Appl Clin Inform 2020; 11 (01) 13-22
- 6 National Cancer Institute. BRIDG: An international standard for biomedical research concepts designed to support computable semantic interoperability. Accessed August 16, 2024 at: https://bridgmodel.nci.nih.gov/
- 7 OHDSI. Standardized Data: The OMOP Common Data Model. Accessed August 16, 2024 at: https://www.ohdsi.org/data-standardization
- 8 Food and Drug Commission. The Future of Drug Safety: Promoting and Protecting the Health of the Public. Accessed August 16, 2024 at: https://www.fda.gov/media/77173/download
- 9 Reisinger SJ, Ryan PB, O'Hara DJ. et al. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc 2010; 17 (06) 652-662
- 10 Stang PE, Ryan PB, Racoosin JA. et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med 2010; 153 (09) 600-606
- 11 The Book of OHDSI. Accessed August 16, 2024 at: https://ohdsi.github.io/TheBookOfOhdsi/
- 12 Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012; 19 (01) 54-60
- 13 Rosenbloom ST, Carroll RJ, Warner JL, Matheny ME, Denny JC. Representing knowledge consistently across health systems. Yearb Med Inform 2017; 26 (01) 139-147
- 14 Suchard MA, Schuemie MJ, Krumholz HM. et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet 2019; 394 (10211): 1816-1826
- 15 Chen R, Suchard MA, Krumholz HM. et al. Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study. Hypertension 2021; 78 (03) 591-603
- 16 Ohno-Machado L, Agha Z, Bell DS. et al; pSCANNER team. pSCANNER: patient-centered Scalable National Network for Effectiveness Research. J Am Med Inform Assoc 2014; 21 (04) 621-626
- 17 OI&T VDL. Computerized Patient Record System (CPRS) User Guide: GUI Version. 2023 . Accessed August 16, 2024 at: https://www.va.gov/vdl/documents/Clinical/Comp_Patient_Recrd_Sys_(CPRS)/cprsguium.pdf
- 18 Hillestad R, Bigelow JH, Chaudhry B. et al. Identity Crisis: An Examination of the Costs and Benefits of a Unique Patient Identifier for the U.S. Health Care System. Santa Monica, CA: RAND Corporation; 2008
- 19 Mainz J, Hess MH, Johnsen SP. The Danish unique personal identifier and the Danish Civil Registration System as a tool for research and quality improvement. Int J Qual Health Care 2019; 31 (09) 717-720
- 20 Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009; 24 (11) 659-667
- 21 Szarfman A, Levine JG, Tonning JM. et al. Recommendations for achieving interoperable and shareable medical data in the USA. Commun Med (Lond) 2022; 2: 86
- 22 FitzHenry F, Resnic FS, Robbins SL. et al. Creating a common data model for comparative effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform 2015; 6 (03) 536-547
- 23 de Mello BH, Rigo SJ, da Costa CA. et al. Semantic interoperability in health records standards: a systematic literature review. Health Technol (Berl) 2022; 12 (02) 255-272
- 24 Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform 2016; 64: 333-341
- 25 Xu Y, Zhou X, Suehs BT. et al. A comparative assessment of observational medical outcomes partnership and mini-sentinel common data models and analytics: implications for active drug safety surveillance. Drug Saf 2015; 38 (08) 749-765
Address for correspondence
Publikationsverlauf
Eingereicht: 06. Mai 2025
Angenommen: 10. Juli 2025
Artikel online veröffentlicht:
26. August 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Congress. 21st Century Cures Act. Secondary 21st Century Cures Act 2016 . Accessed August 16, 2024 at: https://www.congress.gov/114/plaws/publ255/PLAW-114publ255.pdf
- 2 Health IT.gov. Trusted Exchange Framework and Common Agreement (TEFCA). Accessed August 16, 2024 at: https://www.healthit.gov/topic/interoperability/policy/trusted-exchange-framework-and-common-agreement-tefca
- 3 Health IT.gov. Interoperability Standards Advisory (ISA). United States Core Data for Interoperability (USCDI). Accessed August 16, 2024 at: https://www.healthit.gov/isp/
- 4 Choi M, Starr R, Riley M, Duke J. OMOP on FHIR for Data Analytic Application Platform. Accessed December 16, 2024 at: https://www.ohdsi.org/web/wiki/lib/exe/fetch.php?media=resources:omoponfhir_for_data_analytics.pdf/
- 5 Lamer A, Depas N, Doutreligne M. et al. Transforming French electronic health records into the Observational Medical Outcome Partnership's common data model: a feasibility study. Appl Clin Inform 2020; 11 (01) 13-22
- 6 National Cancer Institute. BRIDG: An international standard for biomedical research concepts designed to support computable semantic interoperability. Accessed August 16, 2024 at: https://bridgmodel.nci.nih.gov/
- 7 OHDSI. Standardized Data: The OMOP Common Data Model. Accessed August 16, 2024 at: https://www.ohdsi.org/data-standardization
- 8 Food and Drug Commission. The Future of Drug Safety: Promoting and Protecting the Health of the Public. Accessed August 16, 2024 at: https://www.fda.gov/media/77173/download
- 9 Reisinger SJ, Ryan PB, O'Hara DJ. et al. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc 2010; 17 (06) 652-662
- 10 Stang PE, Ryan PB, Racoosin JA. et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med 2010; 153 (09) 600-606
- 11 The Book of OHDSI. Accessed August 16, 2024 at: https://ohdsi.github.io/TheBookOfOhdsi/
- 12 Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012; 19 (01) 54-60
- 13 Rosenbloom ST, Carroll RJ, Warner JL, Matheny ME, Denny JC. Representing knowledge consistently across health systems. Yearb Med Inform 2017; 26 (01) 139-147
- 14 Suchard MA, Schuemie MJ, Krumholz HM. et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet 2019; 394 (10211): 1816-1826
- 15 Chen R, Suchard MA, Krumholz HM. et al. Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study. Hypertension 2021; 78 (03) 591-603
- 16 Ohno-Machado L, Agha Z, Bell DS. et al; pSCANNER team. pSCANNER: patient-centered Scalable National Network for Effectiveness Research. J Am Med Inform Assoc 2014; 21 (04) 621-626
- 17 OI&T VDL. Computerized Patient Record System (CPRS) User Guide: GUI Version. 2023 . Accessed August 16, 2024 at: https://www.va.gov/vdl/documents/Clinical/Comp_Patient_Recrd_Sys_(CPRS)/cprsguium.pdf
- 18 Hillestad R, Bigelow JH, Chaudhry B. et al. Identity Crisis: An Examination of the Costs and Benefits of a Unique Patient Identifier for the U.S. Health Care System. Santa Monica, CA: RAND Corporation; 2008
- 19 Mainz J, Hess MH, Johnsen SP. The Danish unique personal identifier and the Danish Civil Registration System as a tool for research and quality improvement. Int J Qual Health Care 2019; 31 (09) 717-720
- 20 Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009; 24 (11) 659-667
- 21 Szarfman A, Levine JG, Tonning JM. et al. Recommendations for achieving interoperable and shareable medical data in the USA. Commun Med (Lond) 2022; 2: 86
- 22 FitzHenry F, Resnic FS, Robbins SL. et al. Creating a common data model for comparative effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform 2015; 6 (03) 536-547
- 23 de Mello BH, Rigo SJ, da Costa CA. et al. Semantic interoperability in health records standards: a systematic literature review. Health Technol (Berl) 2022; 12 (02) 255-272
- 24 Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform 2016; 64: 333-341
- 25 Xu Y, Zhou X, Suehs BT. et al. A comparative assessment of observational medical outcomes partnership and mini-sentinel common data models and analytics: implications for active drug safety surveillance. Drug Saf 2015; 38 (08) 749-765



